港股異動 | 中華銀科技(0515.HK)暴漲32% 擬溢價100%增發2.86億股 淨籌2840萬港元
格隆匯2月18日丨中華銀科技(0515.HK)暴漲32%,報0.066港元,總市值1.87億港元。中華銀科技公吿,於2022年2月17日,公司與認購人訂立認購協議,據此,公司已有條件同意配發及發行,而認購人已同意認購合共2.86億股認購股份,認購價為每股認購股份0.10港元。認購價每股認購股份0.10港元較股份於2022年2月17日(即認購協議日期)在聯交所所報的收市價每股0.05港元溢價100%。認購事項的所得款項總額及淨額預計分別約為2860萬港元及2840萬港元。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.